Education
About Us
Working with TipRanks
Follow Us
Alignment Healthcare (ALHC)
NASDAQ:ALHC
ALHC Stock Chart & Stats
$18.22
$0.17(1.45%)
At close: 4:00 PM EST
$18.22
$0.17(1.45%)
Day’s Range― - ―
52-Week Range$11.63 - $23.87
Previous CloseN/A
Volume165.75K
Average Volume (3M)3.06M
Market Cap
$3.72B
Enterprise Value$3.48B
Total Cash (Recent Filing)$577.94M
Total Debt (Recent Filing)$338.07M
Price to Earnings (P/E)―
Beta0.54
Next Earnings
Apr 30, 2026EPS Estimate
<0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding204,296,500
10 Day Avg. Volume3,930,070
30 Day Avg. Volume3,062,558
Financial Highlights & Ratios
PEG Ratio54.31
Price to Book (P/B)21.81
Price to Sales (P/S)0.99
P/FCF Ratio34.56
Enterprise Value/Market Cap0.94
Enterprise Value/Revenue0.88
Enterprise Value/Gross Profit7.39
Enterprise Value/Ebitda76.97
Forecast
1Y Price Target
$25.14Price Target Upside37.98% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
EPS Forecast (FY)0.12
Revenue Forecast (FY)$5.21B
Bulls Say, Bears Say
Bulls Say
Earnings And ProfitabilityAdjusted EBITDA that exceeded analyst expectations supports upward revisions to profitability forecasts and signals the company is delivering stronger-than-expected operating performance.
Medical Cost Control And MarginsBetter-than-anticipated medical benefit ratio performance and disciplined cost control are likely to drive margin expansion and further improve adjusted EBITDA as membership scales.
Membership Growth And RetentionManagement reports higher-than-expected Medicare Advantage retention and robust new enrollment, indicating sustainable membership growth that should drive revenue expansion.
Bears Say
Medicare Advantage Pricing HeadwindsA flat headline Medicare Advantage rate represents a pricing headwind that could compress revenue per member and pressure near-term profitability.
Regulatory And Payment RiskPotential changes to Medicare Advantage risk adjustment or quality programs pose a regulatory risk that could lower future payments and hurt margins.
Sector Sentiment And Earnings UncertaintyMixed earnings results from large-cap payers increase sector-level uncertainty and could reduce investor appetite for health-plan stocks, weighing on the company's valuation.
Alignment Healthcare News
ALHC FAQ
What was Alignment Healthcare’s price range in the past 12 months?
Alignment Healthcare lowest stock price was $11.63 and its highest was $23.87 in the past 12 months.
What is Alignment Healthcare’s market cap?
Alignment Healthcare’s market cap is $3.72B.
When is Alignment Healthcare’s upcoming earnings report date?
Alignment Healthcare’s upcoming earnings report date is Apr 30, 2026 which is in 50 days.
How were Alignment Healthcare’s earnings last quarter?
Alignment Healthcare released its earnings results on Feb 26, 2026. The company reported -$0.05 earnings per share for the quarter, beating the consensus estimate of -$0.154 by $0.104.
Is Alignment Healthcare overvalued?
According to Wall Street analysts Alignment Healthcare’s price is currently Undervalued.
Does Alignment Healthcare pay dividends?
Alignment Healthcare does not currently pay dividends.
What is Alignment Healthcare’s EPS estimate?
Alignment Healthcare’s EPS estimate is <0.01.
How many shares outstanding does Alignment Healthcare have?
Alignment Healthcare has 204,296,500 shares outstanding.
What happened to Alignment Healthcare’s price movement after its last earnings report?
Alignment Healthcare reported an EPS of -$0.05 in its last earnings report, beating expectations of -$0.154. Following the earnings report the stock price went down -5.877%.
Which hedge fund is a major shareholder of Alignment Healthcare?
Currently, no hedge funds are holding shares in ALHC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Alignment Healthcare Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$25.14 (37.98% Upside)
$25.14 (37.98% Upside)
Blogger Sentiment
Bullish
ALHC Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 42.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $432.2M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.9%
Last 30 Days ▼ 6.1%
Last 30 Days ▼ 6.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
20.91%
12-Months-Change
Fundamentals
Return on Equity
-0.49%
Trailing 12-Months
Asset Growth
36.28%
Trailing 12-Months
Company Description
Alignment Healthcare
Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, and Nevada. It also coordinates and provides covered health care services, including professional, institutional, and ancillary services to members enrolled in certain benefit plans of unaffiliated Medicare Advantage Health Maintenance Organizations. The company was founded in 2013 and is based in Orange, California.
ALHC Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call communicated strong financial and operating progress: substantial membership and revenue growth, margin expansion, positive free cash flow, improved SG&A efficiency, market-quality achievements (100% 4+ star plans) and solid AEP momentum. Management acknowledged near-term headwinds from the final phase-in of V28, policy/rate uncertainty from CMS (advanced rate notice), and a higher first-year MBR driven by a heavier dual/LIS mix. Those risks were framed as manageable given the company’s clinically led model, technology platform and disciplined growth approach. Overall the positives (robust growth, profitability improvements, cash generation, and quality metrics) materially outweigh the moderate regulatory and mix-related lowlights.View all ALHC earnings summariesALHC Stock 12 Month Forecast
Average Price Target
$25.14
▲(37.98% Upside)
Technical Analysis
Ownership Overview
19.20% Insiders
28.56% Mutual Funds
11.52% Other Institutional Investors
28.32% Public Companies and
Individual Investors